India's Concord Biotech climbs on higher quarterly profit
** Concord Biotech CONB.NS shares jump nearly 4% to 1,732 rupees ** Drugmaker extends gains to fourth straight session ** Q4 consol net profit jumps 48% as 35% rev surge outpaces rise in costs ** Trading volume 525k shares vs about 194k 30-day avg ** YTD stock has fallen 21% (Reporting by Hritam Mukherjee in Bengaluru) ((Hritam.Mukherjee@thomsonreuters.com;))
Recent news on Concord Biotech
See all newsIndia's Concord Biotech rises after board to consider bonus share issue
Brief: Concord Biotech Ltd June-Quarter Consol Net Profit 585.3 Million Rupees
Brief: Concord Biotech Completes PPB (Kenya) And NDA (Uganda) Inspection At Unit-Ii Formulation Facility
Brief: Concord Biotech Completes Anvisa Inspection At Limbasi API Manufacturing Facility
India's Concord Biotech jumps to 4-month high after US FDA drug approval